ABBOTT INDIA
|
ABBOTT INDIA Last 5 Year Financial Ratios History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 730.36 | 665.62 | 565.28 | 446.78 | 375.86 |
| CEPS(Rs) | 766.11 | 699.41 | 598.77 | 479.71 | 406.96 |
| DPS(Rs) | 656.00 | 475.00 | 410.00 | 325.00 | 275.00 |
| Book NAV/Share(Rs) | 2,234.20 | 1,978.48 | 1,721.76 | 1,480.48 | 1,306.18 |
| Tax Rate(%) | 25.36 | 25.04 | 25.75 | 25.47 | 26.03 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 26.64 | 25.64 | 24.04 | 21.96 | 21.51 |
| EBIT Margin(%) | 29.67 | 28.76 | 26.97 | 23.50 | 21.86 |
| Pre Tax Margin(%) | 29.31 | 28.59 | 26.77 | 23.20 | 21.48 |
| PAT Margin (%) | 21.88 | 21.43 | 19.88 | 17.29 | 15.89 |
| Cash Profit Margin (%) | 22.95 | 22.52 | 21.05 | 18.57 | 17.20 |
| Performance Ratios | |||||
| ROA(%) | 25.08 | 25.53 | 24.73 | 21.71 | 19.89 |
| ROE(%) | 34.67 | 35.98 | 35.31 | 32.07 | 29.95 |
| ROCE(%) | 46.72 | 47.87 | 47.34 | 42.93 | 40.53 |
| Asset Turnover(x) | 1.15 | 1.19 | 1.24 | 1.26 | 1.25 |
| Sales/Fixed Asset(x) | 11.36 | 12.93 | 15.27 | 13.85 | 13.12 |
| Working Capital/Sales(x) | 3.09 | 1.98 | 3.18 | 3.02 | 1.90 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.09 | 0.08 | 0.07 | 0.07 | 0.08 |
| Receivable days | 19.09 | 19.34 | 19.26 | 20.18 | 19.54 |
| Inventory Days | 47.06 | 41.52 | 38.30 | 44.44 | 51.02 |
| Payable days | 106.98 | 107.54 | 107.36 | 109.28 | 113.47 |
| Valuation Parameters | |||||
| PER(x) | 35.49 | 46.17 | 47.67 | 49.43 | 47.09 |
| PCE(x) | 33.84 | 43.94 | 45.00 | 46.04 | 43.49 |
| Price/Book(x) | 11.60 | 15.53 | 15.65 | 14.92 | 13.55 |
| Yield(%) | 2.53 | 1.55 | 1.52 | 1.47 | 1.55 |
| EV/Net Sales(x) | 7.62 | 9.94 | 9.42 | 8.41 | 7.10 |
| EV/Core EBITDA(x) | 24.23 | 32.32 | 32.40 | 33.09 | 29.93 |
| EV/EBIT(x) | 25.11 | 33.54 | 33.82 | 34.89 | 31.73 |
| EV/CE(x) | 11.07 | 15.04 | 14.90 | 14.11 | 8.29 |
| M Cap / Sales | 7.95 | 10.19 | 9.79 | 8.77 | 7.65 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 8.11 | 9.58 | 9.35 | 8.86 | 14.00 |
| Core EBITDA Growth(%) | 10.66 | 15.80 | 25.12 | 16.73 | 16.22 |
| EBIT Growth(%) | 10.85 | 16.45 | 26.39 | 17.38 | 16.37 |
| PAT Growth(%) | 9.73 | 17.75 | 26.52 | 18.87 | 15.64 |
| EPS Growth(%) | 9.73 | 17.75 | 26.52 | 18.87 | 15.64 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | - |
| Current Ratio(x) | 2.55 | 3.37 | 2.42 | 2.51 | 3.20 |
| Quick Ratio(x) | 1.91 | 2.74 | 1.96 | 1.97 | 2.63 |
| Interest Cover(x) | 84.20 | 166.09 | 130.94 | 80.66 | 57.53 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹58,766.6 Cr | -3.5% | 9% | -18.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,408.0 Cr | 1.8% | 6.8% | 17.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹206,906.0 Cr | 6.7% | 18.5% | 12.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,521.0 Cr | -3.7% | 5.5% | 39.8% | Stock Analytics | |
| CIPLA | ₹119,032.0 Cr | 5.7% | 0.6% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,420.1 Cr | -2% | -15.8% | -8.4% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | -3.5% |
9% |
-18.4% |
| SENSEX | 1.2% |
1.2% |
-5.5% |
You may also like the below Video Courses